Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Drug Payment Changes Should Be ‘Physician-Driven’ – Former Official Blum

This article was originally published in The Pink Sheet Daily

Executive Summary

Former CMS Deputy Administrator Jonathan Blum urges agency to 'build support, build consensus and then test' Part B reforms.

You may also be interested in...



Happy Holidays: ‘Most Favored Nation’ Rule Effective Date Likely To Be Delayed

Either through the courts or a postponement by the Trump administration itself, the Medicare Part B rule seems destined to remain dormant instead of going into effect in January as scheduled.

Oncologists Move Against Medicare Part B Drug Payment, Pricing ‘Attacks’

Remember what happened the last time physician groups opposed federal efforts to curtail Medicare spending on Part B drugs?

Medical Benefit, Hospital Drugs Exempt From Detailed Cost, Coverage Reporting In Final Rule

The most detailed US reporting requirements regarding prescription drug costs and coverage will target medicines reimbursed under the retail pharmacy benefit.

Topics

UsernamePublicRestriction

Register

PS079522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel